Mark Roithmayr, Alzheimer's Drug

Mark Roithmayr leads the Alzheimer's Drug Discovery Foundation (ADDF). See sector focus and contact routes.

About Mark Roithmayr

Mark Roithmayr leads the Alzheimer's Drug Discovery Foundation (ADDF), an organization dedicated to accelerating drug discovery for Alzheimer's disease and related dementias. Under his leadership, the ADDF employs a venture philanthropy model, strategically investing in promising research initiatives globally. These investments are structured with terms comparable to those of traditional venture capital firms, ensuring a professional and impactful approach to funding. All financial returns generated from these investments are reinvested directly into the ADDF's charitable mission, further supporting the development of therapeutics for conditions like Frontotemporal Degeneration (FTD) and other neurodegenerative diseases. This unique model allows the ADDF to drive innovation in the field, focusing on the most impactful scientific advancements worldwide.

Mark Roithmayr at a glance

Role
Chief Executive Officer
Organization
Alzheimer's Drug Discovery Foundation
Location
New York, NY
Investor type
Venture Capital
Focus areas
Biotechnology, Health Care, Therapeutics, Health Diagnostics, Medical, Pharmaceutical, Medical Device, Life Science

Frequently asked about Mark Roithmayr

What does Mark Roithmayr invest in?
Mark Roithmayr at Alzheimer's Drug Discovery Foundation (New York, NY) — sector focus: Biotechnology, Health Care, Therapeutics, Health Diagnostics, Medical, Pharmaceutical, Medical Device, Life Science, Software, Neuroscience.
How do I contact Mark Roithmayr?
Mark Roithmayr's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Mark Roithmayr based?
Mark Roithmayr is based in New York, NY.

Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in New York.

Investors similar to Mark Roithmayr (20)

Browse related investor lists (2)

Compare Mark Roithmayr (8)

Investors like Mark Roithmayr · Full investor directory · Investor access · Company funding database

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades